ArticleAdvances in therapy2021

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population.

Wendy Y Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.